Clinical Trial Update: Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study of genomically guided radiation therapy for treating triple-negative breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Triple Negative Breast Cancer | Phase 2 | Status: RECRUITING